Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
HTHTG Molecular Diagnostics, Inc. logo

HTG Molecular Diagnostics, Inc. (HTGM)

NASDAQ Capital Market · Currency in USD
$0.48 ▲ +0.00 (+0.00%)
At close: Jun 14, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.48
Open
$0.57
Day's Range
$0.48 – $0.48
52 Week Range
$0.46 – $24.96
Volume
725,429
Avg. Volume
258,702
Market Cap
$1.06M
Beta (5Y Monthly)
0.99
PE Ratio (TTM)
--
EPS (TTM)
-$0.24
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$0.17

Profile: HTG Molecular Diagnostics, Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
53
CEO
John L. Lubniewski

Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel.

Earnings

DateEst.Actual
May 10, 2023-$1.94-$2.28Miss
Mar 27, 2023-$2.41-$5.28Miss
Nov 10, 2022-$6.24-$4.92Beat
Aug 11, 2022-$6.96-$6.48Beat
May 12, 2022-$8.52-$9.72Miss
Mar 29, 2022-$7.44-$8.28Miss

Analyst view

Consensus price target
$0.17 ▼ -65.3%
Range $0.17 – $0.17
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on HTGM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.